Josh Gottheimer sold Haemonetics Corporation (NYSE: HAE)
Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 5 trades in Haemonetics Corporation (HAE) since 2020, 3 purchases and 2 sales, worth an estimated $40K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Josh Gottheimer sold $1,001 - $15,000 of Haemonetics Corporation (NYSE: HAE) on September 15, 2020. Since that trade, HAE is down -0.97% against the S&P 500 up +132.26%, an outperformance of -133.24%.
Across these filings, Josh Gottheimer has been a net buyer of HAE (a buy-to-sell ratio of 1.50). The most recent disclosed HAE transaction shown was dated January 25, 2021. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Josh Gottheimer's HAE trades vs the price
HAE is down -0.97% since Josh Gottheimer sold on September 15, 2020, versus +132.26% for the S&P 500.
Performance since this trade
All Josh Gottheimer HAE trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Josh Gottheimer & HAE trading FAQ
Is it legal for Josh Gottheimer to trade Haemonetics Corporation (HAE) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Haemonetics Corporation (HAE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Josh Gottheimer sell HAE?
Josh Gottheimer disclosed a sale of $1,001 - $15,000 of Haemonetics Corporation (HAE) on September 15, 2020, according to public STOCK Act filings.
How has HAE performed since Josh Gottheimer's trade?
Since Josh Gottheimer sold HAE on September 15, 2020, the stock is down -0.97%, versus +132.26% for the S&P 500 over the same period, an outperformance of -133.24%.
How many times has Josh Gottheimer traded HAE?
Josh Gottheimer has disclosed 5 HAE trades since 2020 (3 purchases and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional HAE trades?
Quantellect tracks every disclosed congressional trade in Haemonetics Corporation (HAE) on the Haemonetics Corporation congressional trading page, which aggregates filings across all members of Congress.
Josh Gottheimer's HAE tradesAll congressional filings for Haemonetics CorporationJosh Gottheimer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.